Nerandomilast is posed to be Boehringer Ingelheim’s successor to its blockbuster...
A study led by UCL found that individuals with rare diseases were five times mor...
With Dry January firmly behind us, many adults are prompted to reassess their re...
Relmada has acquired complete ownership rights to Sepranolone, developed for Tou...
Bain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong gr...
The pharmaceutical industry is bracing for potentially major disruptions followi...
Sanofi has agreed to purchase its own shares worth €2bn ($2.08bn), part of a $5....
Alumis and Acelyrin have announced a definitive merger agreement, which will res...
Deals, pipeline updates and geopolitical issues drove the conversation at the 20...
Genentech has shared positive data from the Phase III REGENCY trial with regulat...
AI could deliver substantially greater efficiencies in cell and gene therapy man...
Dr Reddy's Laboratories has signed a licence agreement with Shanghai Henlius Bio...
The UK-based drugmaker reported a 21% increase in annual revenues, reaching £43b...
CagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route...
The FDA has granted orphan drug designation (ODD) and RPDD to Arbor Biotechnolog...
The US Food and Drug Administration (FDA) rejected three prior regulatory applic...
